Pharmaceuticals - Community Register


Community register of orphan medicinal products


Product information

Halofuginone Hydrobromide

EU orphan designation number: EU/3/12/988   
Active ingredient: Halofuginone Hydrobromide
Indication: Treatment of Duchenne muscular dystrophy
Sponsor: Biological Consulting Europe Ltd
Wallace Building, Roslin BioCentre, Roslin, Midlothian, EH25 9PP, United Kingdom

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
30/04/2012 Orphan designation EMA/OD/162/11 (2012)2984 of 26/04/2012
29/08/2014 Change of address of sponsor